A double-masked, placebo-controlled study of fluoxetine for hypochondriasis

Journal of Clinical Psychopharmacology

Volumn 28, Issue 6, 2008, Pages 638-645

  Fallon, Brian A ^a   Petkova, Eva ^a   Skritskaya, Natalia ^a   Sanchez Lacay, Arturo ^a   Schneier, Franklin ^a   Vermes, Donna ^a   Cheng, Jianfeng ^a   Liebowitz, Michael R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMATIZATION; TACHYCARDIA; TREATMENT OUTCOME; TREATMENT RESPONSE; DOSE RESPONSE; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; PATIENT; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; TIME; UNITED STATES;

ADULT; AGED; CONNECTICUT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; HYPOCHONDRIASIS; MALE; MIDDLE AGED; NEW YORK; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59049098393     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31818d21cf     Document Type: Article

References (23)

1. Barsky AJ, Wyshak G, Klerman GL, et al. The prevalence of hypo- chondriasis in medical outpatients. Soc Psychiatry Psychiatr Epidemiol. 1990;25:89-94.
2. Kellner R, Abbott P, Pathak D, et al. Hypochondriacal beliefs and attitudes in family practice and psychiatric patients. Int J Psychiatry Med. 1983;13:127-139.
3. Escobar JI, Gara M, Waitzkin H, et al. DSM-IV hypochondriasis in primary care. Gen Hosp Psychiatry. 1998;20:155-159.
4. Noyes R, Kathol R, Fisher M, et al. The validity of DSM-III-R hypochondriasis. Arch Gen Psychiatry. 1993;50:961-970.
5. Lin EH, Katon W, Von Korff M, et al. Frustrating patients: physician and patient perspectives among distressed high users of medical services. J Gen Intern Med. 1991;6:241-246.
6. Barsky AJ, Wyshak G, Latham KS, et al. Hypochondriacal patients, their physicians, and their medical care. J Gen Intern Med. 1991;6:413-419.
7. Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA. 2004;291:1464-1470.
8. Clark DM, Salkovskis PM, Hackman A, et al. Two psychological treatments for hypochondriasis, a randomized controlled trial. Br J Psychiatry. 1998;173:218-225.
9. Greeven A, Van Balkom AJ, Visser S, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry. 2007;164:91-99.
10. Fallon BA, Liebowitz MR, Salman E, et al. Fluoxetine for hypochon- driacal patients without major depression. J Clin Psychopharmacol. 1993;13:438-441.
11. Fallon BA. Pharmacologic strategies for hypochondriasis. In: Starcevic V, Lipsitt DR, eds. Hypochondriasis: Modern Perspectives on an Ancient Malady. New York, NY: Oxford University Press; 2001:329-351.
12. Pilowsky I. Dimensions of hypochondriasis. Br J Psychiatry. 1967;113: 89-93.
13. Guy W. ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC: US Department of Health, Education, and Welfare; 1976.
14. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.
15. Barsky AJ, Wyshak G, Klerman GL. Transient hypochondriasis. Arch Gen Psychiatry. 1990;47:746-752.
16. Weinstein MC, Berwick DM, Goldman PA, et al. A comparison of three psychiatric screening tests using receiver operating characteristic (ROC) analysis. Med Care. 1989;27:593-607.
17. Beck AT, Steer RA. Beck Depression Inventory Manual. San Antonio, TX: Psychological Corporation, Harcourt Brace; 1993.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
20. Fallon BA, Qureshi AL, Schneier FR, et al. An open trial of ?uvoxamine for hypochondriasis. Psychosomatics. 2003;44:298-303.
21. Oosterban DB, van Balkom AJLM, van Boeijen CA, et al. An open study of paroxetine in hypochondriasis. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:1023-1033.
22. Kjernisted KD, Enns MW, Lander M. An open-label clinical trial of nefazodone in hypochondriasis. Psychosomatics. 2002;43:290-294.
23. Fallon BA, Mathew SJ. Biological therapies for obsessive-compulsive disorder. J Psychiatr Pract. 2000;6:113-128.